Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma (Q34591070)

3 August 2017

1 reference

title

Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma (English)

1 reference

3 August 2017

0 references

1 reference

Tot T

1

1 reference

3 August 2017

publication date

1 April 2002

1 reference

European Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

758-763

1 reference

Treatment of patients with cancer of an unknown primary site

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Adenocarcinoma in females detected in serous effusions. Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

DIFFERENTIATION PATHWAYS IN PRIMARY INVASIVE BREAST CARCINOMA AS SUGGESTED BY INTERMEDIATE FILAMENT AND BIOPATHOLOGICAL MARKER EXPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Keratin expression in the normal breast and in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Cytokeratin intermediate filament expression in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

OV‐TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Systematic reviews of evaluations of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

The cytokeratin profile of medullary carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

Metastatic adenocarcinoma of unknown primary origin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900008-4

7 January 2021

10.1016/S0959-8049(02)00008-4

Identifiers

DOI

1 reference

3 August 2017

1 reference